Test-and-treat approach to HIV/AIDS: a primer for mathematical modeling

被引:18
|
作者
Nah, Kyeongah [1 ,2 ]
Nishiura, Hiroshi [1 ,2 ]
Tsuchiya, Naho [3 ]
Sun, Xiaodan [1 ,4 ]
Asai, Yusuke [1 ,2 ]
Imamura, Akifumi [5 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan
[2] Japan Sci & Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan
[3] Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan
[4] Xi An Jiao Tong Univ, Dept Appl Math, Xian 710049, Shaanxi, Peoples R China
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Infect Dis, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; UNITED-STATES; PREVENTION; INFECTION; ELIMINATION; STRATEGY; UGANDA; IMPACT; STAGE;
D O I
10.1186/s12976-017-0062-9
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The public benefit of test-and-treat has induced a need to justify goodness for the public, and mathematical modeling studies have played a key role in designing and evaluating the test-and-treat strategy for controlling HIV/AIDS. Here we briefly and comprehensively review the essence of contemporary understanding of the test-and-treat policy through mathematical modeling approaches and identify key pitfalls that have been identified to date. While the decrease in HIV incidence is achieved with certain coverages of diagnosis, care and continued treatment, HIV prevalence is not necessarily decreased and sometimes the test-and-treat is accompanied by increased long-term cost of antiretroviral therapy (ART). To confront with the complexity of assessment on this policy, the elimination threshold or the effective reproduction number has been proposed for its use in determining the overall success to anticipate the eventual elimination. Since the publication of original model in 2009, key issues of test-and-treat modeling studies have been identified, including theoretical problems surrounding the sexual partnership network, heterogeneities in the transmission dynamics, and realistic issues of achieving and maintaining high treatment coverage in the most hard-to-reach populations. To explicitly design country-specific control policy, quantitative modeling approaches to each single setting with differing epidemiological context would require multi-disciplinary collaborations among clinicians, public health practitioners, laboratory technologists, epidemiologists and mathematical modelers.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Incorporating social determinants of health into the mathematical modeling of HIV/AIDS
    Robson Bruniera de Oliveira
    Felipe Alves Rubio
    Rodrigo Anderle
    Mauro Sanchez
    Luis Eugenio de Souza
    James Macinko
    Ines Dourado
    Davide Rasella
    Scientific Reports, 12
  • [42] Optimising treatment in the test-and-treat strategy: what are we waiting for?
    Phanuphak, Nittaya
    Seekaew, Pich
    Phanuphak, Praphan
    LANCET HIV, 2019, 6 (10): : E715 - E722
  • [43] Interaction of mathematical modeling and social and behavioral HIV/AIDS research
    Cassels, Susan
    Goodreau, Steven M.
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (02) : 119 - 123
  • [44] "A Bird in the Hand ... " A Commentary on the Test and Treat Approach for HIV
    Charebois, Edwin D.
    Havlir, Diane V.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (15) : 1354 - 1356
  • [45] THE COST-EFFECTIVENESS OF HCV TEST-AND-TREAT AND RISK REDUCTION STRATEGIES AMONG MSM LIVING WITH HIV IN FRANCE
    Castry, Mathieu
    Cousien, Anthony
    Supervie, Virginie
    Velter, Annie
    Ghosn, Jade
    Paltiel, A. David
    Yazdanpanah, Yazdan
    Deuffic-Burban, Sylvie
    HEPATOLOGY, 2021, 74 : 19A - 20A
  • [46] The "test-and-treat'' strategy for H-pylori and dyspepsia is unsafe.
    Sung, JJY
    Lai, MS
    Lao, W
    Li, TH
    Chan, FKL
    Leung, VKS
    Luk, Y
    Kung, NNS
    Ching, JYL
    Wu, JCY
    Lau, JYW
    Chung, SCS
    GASTROENTEROLOGY, 1999, 116 (04) : A321 - A321
  • [47] Point-of-care HPV molecular diagnostics for a test-and-treat model in high-risk HIV populations
    Sayed, Shahin
    Chung, Michael
    Temmermans, Marleen
    LANCET GLOBAL HEALTH, 2020, 8 (02): : E171 - E172
  • [48] Temporal Trends in Helicobacter pylori Eradication Success in a Test-and-Treat Population
    Boltin, Doron
    Schmilovitz-Weiss, Hemda
    Gingold-Belfer, Rachel
    Leibovitzh, Haim
    Snir, Yifat
    Perets, Tsachi Tsadok
    Dickman, Ram
    Levi, Zohar
    Niv, Yaron
    DIGESTION, 2018, 98 (03) : 169 - 174
  • [49] The impact of a test-and-treat strategy for Helicobacter pylori:: the United States perspective
    Peura, DA
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 469 - 473
  • [50] Measures of Performance and Clinical Superiority Thresholds for 'Test-and-treat' Predictive Biomarkers
    Hawkins, Neil
    Bouttell, Janet
    Ponomarev, Dmitry
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2025, 23 (01) : 65 - 74